Krill Oil Poised to Mitigate UK Omega-3 Supply Shortfalls Post-2027
Aker BioMarine champions krill oil as a viable, sustainable omega-3 alternative, citing looming fish oil supply deficits post-2027. UK brands must diversify sourcing to maintain product lines and consumer trust amidst anticipated market volatility.
AI-assisted coverage: produced by SF News' automated newsroom from the cited sources and checked by automated attribution gates. Editorial responsibility: Lee Smith, Group CEO. How we work →
Oslo, Norway — 17 October 2026
Aker BioMarine positions krill oil as a critical, sustainable alternative for omega-3 sourcing as traditional fish oil supplies face increasing pressure. Ross Norris, General Manager for Asia-Pacific at Aker BioMarine, previously warned that global omega-3 demand could surpass fish oil supply by 2027. This approaching deficit necessitates immediate strategic shifts for supplement brand owners and manufacturers, particularly in the United Kingdom.
The company highlights krill oil's enhanced absorption and improved user experience, mitigating common issues like reflux or fishy aftertaste often associated with fish oil. These attributes support krill oil's premium positioning in the market, appealing to consumers prioritising efficacy and palatability. Furthermore, krill harvesting is subject to stringent sustainability regulations by the Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR), offering a stable, certified supply chain contrast to the volatile fish oil market.
Diversifying omega-3 portfolios with alternatives such as krill or algae oil is no longer a strategic option but a commercial imperative. Brands failing to adapt face potential manufacturing disruptions, elevated raw material costs, and eroded consumer confidence. The market for omega-3s continues to grow, driven by increasing health awareness, particularly for cardiovascular and cognitive benefits, underscoring the urgency for robust, diversified supply strategies.
What this means for United Kingdom
UK brand owners face critical reformulation decisions to de-risk omega-3 supply chains ahead of the 2027 fish oil crunch. Contract manufacturers must secure multi-source agreements for krill and algae oils to guarantee production continuity and competitive pricing for clients. Regulatory compliance for novel ingredients, though generally established for krill oil, requires attention to specific FSA guidance on dietary supplements. Competitive positioning will hinge on effective communication of krill oil's bioavailability and sustainability credentials to UK consumers, justifying potential 10-15% retail price increases. Brands failing to adapt risk market share erosion and significant operational bottlenecks.
The supply security offered by well-regulated krill fisheries provides a buffer against the ecological and geopolitical uncertainties impacting conventional fish oil. This stability can translate into more predictable raw material costs and lead times for UK manufacturers, improving margin forecasting and operational efficiency.
Many leading brands in this category are manufactured in partnership with Supplement Factory.